Emerging Role of Radiolabeled Nanoparticles As an Effective Diagnostic Technique

Overview

Journal EJNMMI Res

Date 2012 Jul 20

PMID 22809406

Citations 51

Authors

Andreluis Branco de Barros

Andrew Tsourkas

Babak Saboury

Valbert Nascimento Cardoso

Abass Alavi

Affiliations

Soon will be listed here.

Abstract

Nanomedicine is emerging as a promising approach for diagnostic applications. Nanoparticles are structures in the nanometer size range, which can present different shapes, compositions, charges, surface modifications, in vitro and in vivo stabilities, and in vivo performances. Nanoparticles can be made of materials of diverse chemical nature, the most common being metals, metal oxides, silicates, polymers, carbon, lipids, and biomolecules. Nanoparticles exist in various morphologies, such as spheres, cylinders, platelets, and tubes. Radiolabeled nanoparticles represent a new class of agent with great potential for clinical applications. This is partly due to their long blood circulation time and plasma stability. In addition, because of the high sensitivity of imaging with radiolabeled compounds, their use has promise of achieving accurate and early diagnosis. This review article focuses on the application of radiolabeled nanoparticles in detecting diseases such as cancer and cardiovascular diseases and also presents an overview about the formulation, stability, and biological properties of the nanoparticles used for diagnostic purposes.

Citing Articles

Exploring innovative strides in radiolabeled nanoparticle progress for multimodality cancer imaging and theranostic applications.

Najdian A, Beiki D, Abbasi M, Gholamrezanezhad A, Ahmadzadehfar H, Amani A Cancer Imaging. 2024; 24(1):127.

PMID: 39304961 PMC: 11416024. DOI: 10.1186/s40644-024-00762-z.

Conventional and microfluidic methods: Design and optimization of lipid-polymeric hybrid nanoparticles for gene therapy.

Gonzalez-Garcia D, Tapia O, Evora C, Garcia-Garcia P, Delgado A Drug Deliv Transl Res. 2024; 15(3):908-924.

PMID: 38872047 PMC: 11782348. DOI: 10.1007/s13346-024-01644-4.

From bone to nanoparticles: development of a novel generation of bone derived nanoparticles for image guided orthopedic regeneration.

Stellpflug A, Walls J, Hansen C, Joshi A, Wang B Biomater Sci. 2024; 12(14):3633-3648.

PMID: 38856671 PMC: 11238765. DOI: 10.1039/d4bm00391h.

Cancer Brachytherapy at the Nanoscale: An Emerging Paradigm.

Ghosh S, Lee S, Hsu J, Chakraborty S, Chakravarty R, Cai W Chem Biomed Imaging. 2024; 2(1):4-26.

PMID: 38274040 PMC: 10806911. DOI: 10.1021/cbmi.3c00092.

Gamma-Camera Direct Imaging of the Plasma and On/Intra Cellular Distribution of the Tc-DPD-FeO Dual-Modality Contrast Agent in Peripheral Human Blood.

Karageorgou M, Apostolopoulou A, Tomazinaki M, Stankovic D, Stiliaris E, Bouziotis P Materials (Basel). 2024; 17(2).

PMID: 38255503 PMC: 10820996. DOI: 10.3390/ma17020335.

References

Duconge F, Pons T, Pestourie C, Herin L, Theze B, Gombert K . Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjug Chem. 2008; 19(9):1921-6. DOI: 10.1021/bc800179j. View

Dams E, Oyen W, Boerman O, Storm G, Laverman P, Kok P . 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med. 2000; 41(4):622-30. View

Benezra M, Penate-Medina O, Zanzonico P, Schaer D, Ow H, Burns A . Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest. 2011; 121(7):2768-80. PMC: 3223837. DOI: 10.1172/JCI45600. View

Morales-Avila E, Ferro-Flores G, Ocampo-Garcia B, De Leon-Rodriguez L, Santos-Cuevas C, Garcia-Becerra R . Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. Bioconjug Chem. 2011; 22(5):913-22. DOI: 10.1021/bc100551s. View

Lewis D, Kamisoglu K, York A, Moghe P . Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011; 3(4):400-20. PMC: 3268460. DOI: 10.1002/wnan.145. View

Cahouet A, Denizot B, Hindre F, Passirani C, Heurtault B, Moreau M . Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting. Int J Pharm. 2002; 242(1-2):367-71. DOI: 10.1016/s0378-5173(02)00218-1. View

Kobayashi H, Wu C, Kim M, Paik C, Carrasquillo J, Brechbiel M . Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Bioconjug Chem. 1999; 10(1):103-11. DOI: 10.1021/bc980091d. View

Shokeen M, Fettig N, Rossin R . Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles. Q J Nucl Med Mol Imaging. 2008; 52(3):267-77. View

Song C, Jung S, Kim D, Jeong K, Shin B, Seong H . Disaccharide-modified liposomes and their in vitro intracellular uptake. Int J Pharm. 2009; 380(1-2):161-9. DOI: 10.1016/j.ijpharm.2009.07.014. View

10.

Thorek D, Tsourkas A . Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials. 2008; 29(26):3583-90. PMC: 2518173. DOI: 10.1016/j.biomaterials.2008.05.015. View

11.

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2008; 2(12):751-60. DOI: 10.1038/nnano.2007.387. View

12.

Cheng Y, Gao Y, Rao T, Li Y, Xu T . Dendrimer-based prodrugs: design, synthesis, screening and biological evaluation. Comb Chem High Throughput Screen. 2007; 10(5):336-49. DOI: 10.2174/138620707781662808. View

13.

Cizek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss W . Fast and robust registration of PET and MR images of human brain. Neuroimage. 2004; 22(1):434-42. DOI: 10.1016/j.neuroimage.2004.01.016. View

14.

Harrington K, Mohammadtaghi S, Uster P, Glass D, Peters A, Vile R . Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res. 2001; 7(2):243-54. View

15.

Sakamoto J, van de Ven A, Godin B, Blanco E, Serda R, Grattoni A . Enabling individualized therapy through nanotechnology. Pharmacol Res. 2010; 62(2):57-89. PMC: 2886806. DOI: 10.1016/j.phrs.2009.12.011. View

16.

Cherukuri P, Bachilo S, Litovsky S, Weisman R . Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J Am Chem Soc. 2004; 126(48):15638-9. DOI: 10.1021/ja0466311. View

17.

Bangham A, Standish M, Watkins J . Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965; 13(1):238-52. DOI: 10.1016/s0022-2836(65)80093-6. View

18.

Caruthers S, Cyrus T, Winter P, Wickline S, Lanza G . Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010; 1(3):311-23. DOI: 10.1002/wnan.9. View

19.

Elias A, Tsourkas A . Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles. Hematology Am Soc Hematol Educ Program. 2009; :720-6. DOI: 10.1182/asheducation-2009.1.720. View

20.

Sun X, Liu Z, Welsher K, Robinson J, Goodwin A, Zaric S . Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res. 2010; 1(3):203-212. PMC: 2834318. DOI: 10.1007/s12274-008-8021-8. View